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Women with Fibromyalgia Have Lower Levels of Calcium, 
Magnesium, Iron and Manganese in Hair Mineral Analysis
Little is known about hair mineral status in fibromyalgia patients. This study evaluated the 
characteristics of hair minerals in female patients with fibromyalgia compared with a 
healthy reference group. Forty-four female patients diagnosed with fibromyalgia according 
to the American College of Rheumatology criteria were enrolled as the case group. Age- 
and body mass index-matched data were obtained from 122 control subjects enrolled 
during visit for a regular health check-up. Hair minerals were analyzed and compared 
between the two groups. The mean age was 43.7 yr. General characteristics were not 
different between the two groups. Fibromyalgia patients showed a significantly lower level 
of calcium (775 µg/g vs 1,093 µg/g), magnesium (52 µg/g vs 72 µg/g), iron (5.9 µg/g vs 7.1 
µg/g), copper (28.3 µg/g vs 40.2 µg/g) and manganese (140 ng/g vs 190 ng/g). Calcium, 
magnesium, iron, and manganese were loaded in the same factor using factor analysis; 
the mean of this factor was significantly lower in fibromyalgia group in multivariate 
analysis with adjustment for potential confounders. In conclusion, the concentrations of 
calcium, magnesium, iron, and manganese in the hair of female patients with fibromyalgia 
are lower than of controls, even after adjustment of potential confounders. 
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INTRODUCTION
Fibromyalgia is characterized by chronic generalized pain, mus-
cle tenderness, and fatigue. The etiology and mechanisms of fi-
bromyalgia are not well understood, as is the pattern of high 
prevalence of fibromyalgia in middle age and subsequent de-
crease (1). Fibromyalgia is much more prevalent in women than 
in men (2).
  Some hypotheses have been introduced to explain the patho-
physiology of fibromyalgia. Explanations for the pain include 
peripheral muscle involvement (3), central pain mechanism (4), 
multiple neurotransmitter hypothesis (5, 6), and psychiatric as-
pects (7, 8). Various trials have been conducted to evaluate these 
suggested sources, but success has been limited; a longitudinal 
study reported that about half of fibromyalgia patients were not 
satisfied their health-related quality of life in spite of various treat-
ments (9). Therefore, a new approach to understand this disease 
is required. 
  Several studies have explored the relationship between fibro-
myalgia and oxidative stress (10, 11). Still other studies investi-
gated elemental composition of patients with fibromyalgia, but 
they surveyed only in blood and urine samples (12-14). The lat-
ter studies, while potentially useful, overlooked the mineral con-
tent of hair. Hair mineral assay can be an effective method to 
deduce intracellular status. Some studies tried to find the char-
acteristics of the elements in some diseases, including fibromy-
algia (15-17). The present study investigated the elemental char-
acteristics in the hair of women with fibromyalgia, and compared 
the data with those from healthy age- and body mass-matched 
women. 
MATERIALS AND METHODS
Study Participants and design
This cross-sectional study was conducted in case-control design. 
Forty four female patients with fibromyalgia aged 29-57 yr were 
recruited at the Department of Rheumatology and Department 
of Family Practice and Community Health, Ajou University Hos-
pital, from March-August, 2010. The diagnosis of fibromyalgia 
was based on the American College of Rheumatology (ACR) cri-
teria (18). Age- and body mass index (BMI)-matched healthy 
control female patients without fibromyalgia, who were recruit-
ed and provided informed consent during their visit to the health 
promotion center, Ajou University Hospital, were the reference Kim Y-S, et al.  •  Hair Minerals in Fibromyalgia Patients
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group. Women who had diabetes, thyroid diseases, rheumato-
logic disorders, cancers, and psychological problems were ex-
cluded from the reference group. 
Analysis of hair minerals
For analysis of hair minerals, all participants were asked not to 
chemically process their hair (i.e., no dyeing, perms, or frosting) 
for at least 2 weeks prior to hair sample acquisition. The hair had 
also to be free of all gels, oils, and hair creams before sample col-
lection. Approximately 300 mg of hair were obtained from four to 
five different locations of the posterior vertex region of the scalp 
using stainless steel scissors. The only proximal portion (within 
3.8 cm of the root) was used as the sample. The cut hair was placed 
directly into a clean hair specimen envelope normally provided 
by the laboratory and then sealed with the envelope’s glue flap. 
The hair samples were not washed for the assays. ICP-Mass Spec-
trometry (Perkin-Elmer, Waltham, MA, USA) was applied to rou-
tine elemental analysis. A licensed and certified clinical labora-
tory performed all testing in a trace element laboratory clean 
room environment, utilized the latest microwave temperature-
controlled digestion technique.
Anthropometry
Height (cm) and weight (0.1 kg units) measurements were tak-
en while each participant was lightly clothed. BMI was calculat-
ed with measured height and weight (kg/m
2). Waist circumfer-
ence was measured at the central part between the twelfth rib 
and iliac crest by a trained nurse in the outpatient clinic of the 
Department of Family Practice and Community Health. 
Statistical analyses
The amount of each element was recorded per 1 g hair. All data 
below detection limit were replaced by the detection limit of each 
element. The values were expressed as mean ± standard devia-
tion, mean (95% confidential interval), and number (proportion) 
for descriptive statistics. For the variables of the minerals that 
had a right-skewed distribution, the values were analyzed using 
logarithmically transformed data. Independent sample t test was 
used for the comparison of mean values of age, waist circumfer-
ence, body weight, height, BMI, and minerals between the fibro-
myalgia group and the reference group. Chi-square test was used 
for the comparison of proportion of current smokers and cur-
rent drinkers between the groups. To study the relationship be-
tween minerals and fibromyalgia, principal component analy-
sis was used to reduce the dimensionality of the mineral data. 
The factors with eigenvalues  > 1.0 were retained in the analysis. 
A varimax orthogonal rotation was applied to identify any dis-
tinct latent factors and to facilitate interpretation. The differenc-
es of factors between the groups were analyzed using t test. For 
multivariate analysis, each factor entered in the logistic regres-
sion model (Model 1), and age was adjusted (Model 2). In the 
final model (Model 3), waist circumference, alcohol and smok-
ing were also adjusted. For multivariate analysis, age was cate-
gorized into three groups (< 40, 40-49, and ≥ 50 yr), and waist 
circumference was divided into central obesity ( ≥ 80 cm) or non-
obesity.  A P value < 0.05 was considered statistically significant. 
SPSS version 18 (SPSS, Chicago, IL, USA) was used for all statis-
tical analyses. 
Ethics statement
This study was approved by the institutional review board of Ajou 
Table 1. General characteristics of the subjects
Variables
Total
(n = 166)
Case group
(n = 44)
Reference 
group
(n = 122)
P
Age (yr)   43.7 ± 8.0   42.5 ± 6.9   44.2 ± 8.3 0.224 
WC (cm)   77.1 ± 7.5   77.7 ± 8.3   76.9 ± 7.2 0.549 
BMI (kg/m
2)   22.5 ± 2.8   22.3 ± 2.8   22.5 ± 2.9 0.669 
Body weight (kg)   56.5 ± 7.6   56.0 ± 7.2   56.7 ± 7.8 0.602 
Height (cm) 158.5 ± 4.6 158.4 ± 4.5 158.5 ± 4.6 0.945 
Current smoker 4 (2.4%) 1 (2.3%) 3 (2.5%) 1.000 
Current drinker 26 (15.7%)   9 (20.5%) 17 (13.9%) 0.436
All values are expressed mean ± SD or number (proportion). P values are calculated 
by independent t-test or chi-square test. WC, waist circumference; BMI, body mass 
index.
Table 2. The concentrations of elements between groups
Variables   Total (n = 166) Reference group (n = 122) Case group (n = 44) P
Ca (µg/g) 998 (537-1,854) 1,093 (591-2,020) 775 (439-1,366) 0.001 
Mg (µg/g) 66 (32-137) 72 (36-147) 52 (25-107) 0.008 
Na (µg/g) 74 (28-195) 72 (27-195) 78 (31-195) 0.617 
K (µg/g) 60 (23-157) 56 (23-138) 75 (25-219) 0.121 
Cu (µg/g) 36.6 (14.7-91.2) 40.2 (16.1-100.0) 28.3 (11.8-68.1) 0.029 
Zn (µg/g) 165 (124-221) 165 (125-217) 167 (120-232) 0.816 
P (µg/g) 144 (116-178) 143 (116-176) 146 (116-183) 0.589 
Fe (µg/g) 6.76 (4.55-10.05) 7.10 (4.73-10.66) 5.90 (4.21-8.26) 0.007 
Mn (ng/g) 180 (80-410) 190 (80-480) 140 (80-260) 0.029 
Cr (ng/g) 420 (330-550) 420 (320-540) 440 (360-550) 0.157 
Se (ng/g) 560 (320-1,000) 580 (320-1,070) 510 (320-810) 0.156 
Data shown as mean (95% confidential interval). Logarithmic transformations for calculations back-transformed to natural values. P values are calculated with logarithmically 
transformed variables by independent sample t-test.Kim Y-S, et al.  •  Hair Minerals in Fibromyalgia Patients
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University Hospital, Suwon, Korea (AJIRB-MED-OBS-10-003). 
All participating patients provided informed consent and agreed 
to provide a hair sample.
 
RESULTS
Forty-four women with fibromyalgia were enrolled in the case 
group. Among the 683 women who had their hair tested, 205 had 
appropriate anthropometry and historical data. Eighty-three 
women were excluded from the reference group. The mean age 
of the all subjects was 43.7 ± 8 yr and there was no significant 
difference between the cases and the reference group. The val-
ues of the anthropometric measures and proportions of current 
smokers and drinkers were not statistically different between 
the groups (Table 1). The results of hair minerals analysis revealed 
statistical differences in the levels of calcium (1,093 µg/g for ref-
erence group, 775 µg/g for fibromyalgia group), magnesium (72 
µg/g for reference group, 52 µg/g for fibromyalgia group), cop-
per (40.2 µg/g for reference group, 28.3 µg/g for fibromyalgia 
group), iron (7.1 µg/g for reference group, 5.9 µg/g for fibromy-
algia group), and manganese (190 ng/g for reference group, 140 
ng/g for fibromyalgia group) (Table 2). 
  Factor analysis was used to evaluate the relationship among 
significant hair minerals. Hair mineral elements were reduced 
to three factors by principal component analysis. Factor load-
ings after varimax rotation are shown in Table 3. Calcium, mag-
nesium, iron, and manganese were loaded at Factor 1. Factor 2 
was characterized by sodium, potassium, and chromium. Zinc 
and selenium comprised Factor 3. The mean of Factor 1 for the 
fibromyalgia group was significantly lower than that for the ref-
erence group by t test (-0.374 for fibromyalgia group, 0.135 for 
reference group, P = 0.004) (Table 4). According to the result of 
multivariate analysis, the mean of Factor 1 for the fibromyalgia 
group was lower than that for the reference group even after ad-
justment of multiple potential confounders (Table 5). 
 
DISCUSSION
In this study, hair minerals in fibromyalgia patients were ana-
lyzed and compared with those in a reference group of age- and 
BMI-matched female patients who did not have fibromyalgia. 
Univariate analyses revealed differences between the two groups 
in several elements such as calcium, magnesium, copper, iron, 
and manganese. Upon principal component analysis, calcium, 
magnesium, iron, and manganese were the components of a 
single factor, which was significantly lower in the fibromyalgia 
group even after adjustment of multiple potential confounders.
  Several mechanisms have been suggested to explain the patho-
physiology of fibromyalgia. Alterations in muscle are an impor-
tant aspect of fibromyalgia (19, 20). Another hypothesis involves 
impaired functioning of the hypothalamic-pituitary-adrenal axis 
(21). Sleep pattern change is also frequently observed in fibro-
myalgia patients (22). A greater understanding of cellular mech-
anisms is needed to explain these hypotheses. Therefore, it is 
important to detect the alteration of trace minerals in fibromy-
algia patients.
  A few studies have probed the characteristics of elements in 
fibromyalgia patients. Rosborg et al. (13) investigated the min-
erals in the serum and urine of fibromyalgia patients, but failed 
to find significant characteristics. The levels of trace minerals in 
fibromyalgia patients are controversial. In one study, serum se-
lenium, magnesium, zinc, vitamin B1, B2, vitamins A and E were 
Table 3. Principal component analysis with varimax rotation for nutritional elements
Variables Factor 1 Factor 2 Factor 3
Ca 0.92  -0.21  0.04 
Mg 0.88  -0.16  0.01 
Na 0.09  0.86  -0.18 
K -0.17  0.82  -0.35 
Cu 0.28  -0.15  0.23 
Zn 0.10  -0.12  0.57 
P 0.06  0.05  0.70 
Fe 0.90  -0.02  -0.03 
Mn 0.65  0.18  -0.03 
Cr -0.12  0.66  0.36 
Se -0.33  -0.07  0.53 
Eigenvalue 3.11  1.99  1.44 
Total variance (%) 28.25  18.12  13.14 
Cumulative variance (%) 28.25  46.37  59.51 
Table 4. The differences of factors between the two groups
Factors Reference group Fibromyalgia group P
Factor 1  0.135 ± 1.005 -0.374 ± 0.896 0.004 
Factor 2 -0.061 ± 1.026    0.17 ± 0.915 0.191 
Factor 3  0.017 ± 1.017 -0.047 ± 0.962 0.715 
Data shown as mean ± SD. P values are calculated by independent sample t-test.
Table 5. The differences of factors with multivariate analysis
Factors
Model 1 Model 2 Model 3
OR P OR P OR P
Factor 1 0.569 (0.385-0.842) 0.005   0.602 (0.399-0.906) 0.015 0.596 (0.391-0.909) 0.016
Factor 2 1.261 (0.891-1.784) 0.191     1.32 (0.919-1.897) 0.133 1.319 (0.917-1.896) 0.135
Factor 3 0.947 (0.663-1.352) 0.764 0.952 (0.657-1.38) 0.795   0.95 (0.645-1.398) 0.793
Odds ratio (OR) shown as OR (95% confidential interval). P values are calculated by logistic regression analysis. Model 1, without any confounder; Model 2, adjusted for catego-
rized age; Model 3, adjusted for categorized age, categorized WC, alcohol and smoking.Kim Y-S, et al.  •  Hair Minerals in Fibromyalgia Patients
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analyzed; magnesium in leukocytes was elevated, but no signif-
icant differences among the other minerals were found (12). 
  Hypocalcemia can cause extensive spasm of skeletal muscle, 
cramps and tetany (23). However, most patients with muscle pain 
including fibromyalgia have a normal range of serum calcium. 
It is also true that even if calcium concentration in the blood is 
normal, the intracellular calcium level can be different. Magaldi 
et al. (24) investigated the difference of intracellular calcium lev-
el between fibromyalgia cases and controls. They found that in 
fibromyalgia patients the intracellular calcium concentration is 
significantly reduced in comparison to that of healthy controls, 
which may be potentially responsible for muscular hypertonus 
(24). In another study, lower bone mineral density was noted in 
fibromyalgia patients than in controls, perhaps an indirect indi-
cation of impaired calcium metabolism in fibromyalgia (25). 
  Hypomagnesemia causes generalized alterations in neuro-
muscular function and is related with muscle weakness and 
cramps (23). Hypomagnesemia can cause impaired synthesis 
of 1, 25(OH)2D; vitamin D deficiency can also cause hypocalce-
mia (23). Some studies have provided evidence of lowered mag-
nesium status in fibromyalgia and other conditions. In one study, 
fibromyalgia cases and controls were investigated for trace min-
erals (14). Zinc and magnesium in fibromyalgia patients was 
lower than those in controls, but selenium did not differ appre-
ciably. Low magnesium concentration in erythrocytes was re-
ported in chronic sleep deprivation (26). Magnesium deficit was 
noted in some individuals with chronic fatigue (27). A double-
blind study had been carried out to test the efficacy and the safe-
ty of malic acid and magnesium supplementation for treatment 
of fibromyalgia (28). To date, magensium supplementation has 
been applied to non-pharmacological therapy (29).
  A study investigated malondialdehyde and superoxide disu-
mutase in 85 female fibromyalgia patients and controls; and re-
ported that oxidant/antioxidant balances are changed in fibro-
myalgia (10). Another study investigated 30 female fibromyalgia 
patients in comparison with controls. This study evaluated su-
peroxide dismutase, xanthine oxidase, adenosine deaminase 
enzyme activity, thiobarbituric acid reactive substances and ni-
tric oxide levels; high level of thiobarbituric acid reactive sub-
stances and low level of nitric oxide were detected in fibromyal-
gia (11). These collective data imply that the scavenging capaci-
ty of reactive oxygen species is reduced in fibromyalgia.
  In humans, three forms of superoxide dismutase are present. 
They contain some minerals such as copper, zinc and manga-
nese. Manganese, especially, is an essential element comprising 
superoxide dismutase 2 that functions in antioxidant defense in 
mitochondria (30). Considering that oxidant/antioxidant bal-
ances were altered in fibromyalgia, an insufficiency of manga-
nese might be related with pathophysiology of fibromyalgia.
  There are some limitations in our study. First, since the study 
design was cross-sectional, causality cannot be explained. To as-
certain causality, a longitudinal study would be required. Sec-
ond, the controls in our study were patients with other problems. 
However, factors associated with fibromyalgia were excluded 
according to the criteria in our study. Third, the mineral assay 
was done only in hair tissue. Minerals in serum and urine were 
not analyzed, so the consistency with prior studies could not be 
confirmed. However, the hair mineral assay is a good method 
to explore the mineral status at the cellular level. 
  In conclusion, the concentrations of calcium, magnesium, 
iron, and manganese in the hair of female patients with fibro-
myalgia are lower than of controls, even after adjustment of po-
tential confounders. Whether supplementation with minerals 
would have an impact on the progress of fibromyalgia should 
be considered in more detail. Also, factors influencing the pain 
in fibromyalgia patients should be further evaluated. 
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